enVVeno Medical

IN THE PRESS

Biotech Beach

Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium

April 24, 2024

·

7 min read

Biotech Beach

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024

April 16, 2024

·

6 min read

Biotech Beach

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting

March 6, 2024

·

7 min read

Biotech Beach

Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024

February 20, 2024

·

5 min read

Biotech Beach

enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium

November 16, 2023

·

7 min read

enVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate Update

October 26, 2023

·

5 min read

Biotech Beach

enVVeno Medical Announces Private Placement of $28 Million

October 6, 2023

·

5 min read

JOBS